Top NYC, NY Health Tech Companies (548)
Wellthy helps families balance work and caregiving responsibilities through a combination of precision technology and human expertise – a care concierge to help families navigate any care situation or challenge. By alleviating caregiving demands for caregivers through a digital dashboard and real-time advice from care experts, Wellthy makes it easier for caregivers to take care of their own health, reduce stress, save money, and stay engaged in their work and their lives while taking care of their loved ones. Nearly 2 million people have direct access to Wellthy’s services through some of the largest and best-known health plans and employers across the country. And we're hiring! Visit https://resources.wellthy.com/careers/ to see all of our open opportunities, or send your resume and cover letter to [email protected]. At Wellthy, we passionately care about our hiring processes and supporting candidates for roles. When we are hiring for new roles at Wellthy, you will a) only hear from official recruiters at Wellthy with a "@wellthy.com" email address, and b) see roles posted on our website's Careers page – https://resources.wellthy.com/careers/ – and our official social media accounts. If you find a role at Wellthy listed on or from any other source, double-check to make sure it's a role listed on our Careers page or on Wellthy’s social channels. Our team at Wellthy takes hiring seriously, and we care deeply about every candidate’s experience. Don’t ever hesitate to reach out to us at [email protected] if you have any questions about roles at Wellthy
At PathAI our mission is to improve patient outcomes with AI-powered technology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning.
Twentyeight Health is a women's health platform focused on increasing reproductive & sexual health care access to underserved communities.
Fit4D delivers patient programs through a combination of technology platform and human-based touch points. The company's clinical team, comprised of dietitians, exercise physiologists, nurses, and social workers, many of whom are also certified diabetes educators (CDEs), focuses on empowering people with diabetes to deliver personalized care with increased member volumes. The platform provides electronic interactions in patient-preferred modalities (e.g. phone, email, text, web, video, etc.) that address patient-specific issues (e.g. overwhelmed, fear of needles, language barriers, etc.), in the patient's preferred format (e.g. articles, videos, webinars, etc.) and at the patient's preferred time of day (after putting children to bed, before work in the morning, etc.).
Surgarai is an early-stage medical technology startup. The Company utilizes augmented reality to improve procedures and surgeries by providing real-time access to crucial data. With its technology, the Company seeks to capitalize on the intersection of the lucrative medical device and augmented reality markets.
Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We aim to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.
Genomic Prediction provides advanced genomic tests which improve IVF health outcomes. Genomic Prediction Inc. (GP) was incorporated in Delaware, May 1, 2017. The research insights which led to the creation of GP stretch back much further. Research and data exchange agreements to develop molecular methodology, signed with some of the largest biotechnology vendors in the world, were ongoing as early as 2015. In the decade prior, the founders’ work in embryology, detection of chromosomal abnormality, computational genomics, algorithms, and polygenic architecture led to GP’s superior and innovative methodology for the genetic testing of human embryos. GP’s products incorporate fundamental improvements on existing methods. GP offers IVF parents a cost-effective means to evaluate genetic risk due to chromosomal abnormality (ploidy), single-gene mutations, and polygenic diseases. Accurate understanding of the genomic architecture of human disease requires larger training datasets, greater accuracy, and a more rigorous, empirical basis of computational modeling (machine learning) than implemented in the past with simpler technologies and simpler computational methods. GP represents the next step in embryo genetic testing, combining dense, genome-wide genotyping methods with sophisticated validation-focused modeling, suitable for the information age.
Picofemto creates easy-to-use, cloud-based software that helps medical professionals analyze raw primary medical data at the point of diagnosis or evaluation.
